Nosopharm
Lyon, FranceEntry
2019
Hold
7yr
Status
Active
Who owns Nosopharm?
Nosopharm is currently owned by Elaia Partners through Elaia DV5 (2026 vintage), since 2019. Across its history, Nosopharm has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2017 · present
Alto Partners SGRActive
2017 · present(9yr) · Alto Capital V · 2022 · Small-Mid Buyout
Auriga PartnersActive
2017 · present(9yr) · Auriga Cyber Ventures · 2022 · VC
Elaia PartnersActive
2019 · present(7yr) · Elaia DV5 · 2026 · VC
More from Elaia DV5
Other portfolio companies in the same fund.
US
UK
SpainMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Nosopharm
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Nosopharm.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue